COPD Clinical Trials near Charlotte, NC
13 studies for COPD are recruiting at 20 sites within 50 miles of Charlotte, North Carolina, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all COPD trials in the US or all trials near Charlotte.
Recruiting now
COPD studies enrolling near Charlotte
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Charlotte, NC); Research Site (Gaffney, SC)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
NCT07053423
- Phase 4
- Ages 40 to 85 years
- Sex: All
Nearest site: American Health Research - Charlotte- Site Number : 8400013 (Charlotte, NC)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
NCT07646587
- Phase 2
- Ages 40 to 80 years
- Sex: All
Nearest site: WB Contracted Clinical Research Site (Charlotte, NC)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Huntersville, NC); Research Site (Statesville, NC)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Rock Hill, SC); Research Site (Kings Mountain, NC)
- Distance to nearest recruiting site
- ~23 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694
- Phase 2/3
- Ages 35 to 80 years
- Sex: All
Nearest sites: Clinical Research of Rock Hill (Rock Hill, SC); Velocity Clinical Research, Gaffney (Gaffney, SC)
- Distance to nearest recruiting site
- ~23 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
NCT07684820
- Phase 2
- Ages 40 to 85 years
- Sex: All
Nearest sites: Clinical Research of Rock Hill (Rock Hill, SC); Carolina Research Center, Inc. (Shelby, NC)
- Distance to nearest recruiting site
- ~23 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
NCT06959095
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: GSK Investigational Site (Rock Hill, SC)
- Distance to nearest recruiting site
- ~23 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
NCT07177339
- Phase 3
- Ages 40 to 75 years
- Sex: All
Nearest site: GSK Investigational Site (Rock Hill, SC)
- Distance to nearest recruiting site
- ~23 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: MD First Research - Lancaster- Site Number : 8400102 (Lancaster, SC); Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013 (Hickory, NC)
- Distance to nearest recruiting site
- ~35 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest site: Research Site (Lancaster, SC)
- Distance to nearest recruiting site
- ~35 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Piedmont Healthcare - Family Medicine- Site Number : 8400022 (Statesville, NC)
- Distance to nearest recruiting site
- ~39 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: GSK Investigational Site (Shelby, NC)
- Distance to nearest recruiting site
- ~39 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a COPD clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.